Sources | Names Used |
---|---|
CTRPv2 | selumetinib:decitabine (4:1 mol/mol) |
PharmacoGx | selumetinib:decitabine (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SLC28A3 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.007 |
mRNA | GOLT1A | CTRPv2 | pan-cancer | AAC | 0.097 | 0.007 |
mRNA | TTLL7 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.007 |
mRNA | PLPP3 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.007 |
mRNA | DAO | CTRPv2 | pan-cancer | AAC | 0.089 | 0.007 |
mRNA | SIGLEC8 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.007 |
mRNA | TSNAX-DISC1 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.007 |
mRNA | SLC25A45 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.007 |
mRNA | C11orf65 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.007 |
mRNA | GPA33 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |